• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Solara Active Pharma Sciences Limited — Updates, 23-07-2026: Press Release

    23-07-2026 | 01:36 pm

    Solara reported strong Q1’27 with base business revenue up 24% YoY to ₹30.77 Cr and EBITDA up 8% to ₹7.22 Cr. Overall, highest EBITDA (₹6.35 Cr) and PAT (₹1.63 Cr) in 18 quarters. Debt reduced by ₹13.46 Cr to ₹47.95 Cr. Strategic options for challenging Ibuprofen business are under evaluation.

    No comments yet. Be the first to comment!

    All announcements from Solara Active Pharma Sciences Limited